Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM)

  • Tara Gregory
  • , Adam D. Cohen
  • , Caitlin L. Costello
  • , Syed Abbas Ali
  • , Jesus G. Berdeja
  • , Eric M Ostertag
  • , Christopher Martin
  • , Devon J Shedlock
  • , Michelle Lynn Resler
  • , Matthew A. Spear
  • , Robert Z. Orlowski
  • , Krina K. Patel
  • Colorado Blood Cancer Institute, Denver, CO
  • University of Pennsylvania
  • University of California, San Diego
  • Johns Hopkins University
  • Sarah Cannon Research Institute
  • Poseida Therapeutics, Inc., San Diego, CA
  • Poseida Therapeutics, San Diego, CA
  • University of Texas MD Anderson Cancer Center

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume132
DOIs
StatePublished - Nov 29 2018
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this